Manulife (Manufacturers Life Insurance)’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Buy
90,634
+21,083
+30% +$717K ﹤0.01% 1379
2025
Q4
$2.15M Buy
69,551
+1,175
+2% +$28.5K ﹤0.01% 1487
2025
Q3
$1.2M Sell
68,376
-18,721
-21% -$250K ﹤0.01% 1761
2025
Q2
$994K Buy
87,097
+36,987
+74% +$377K ﹤0.01% 1827
2025
Q1
$370K Buy
50,110
+435
+0.9% +$4.6K ﹤0.01% 2272
2024
Q4
$916K Buy
49,675
+3,481
+8% +$74.2K ﹤0.01% 1945
2024
Q3
$1.2M Buy
+46,194
New +$1.06M ﹤0.01% 1829

Other funds holding MBX

Manulife (Manufacturers Life Insurance)'s MBX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its MBX Biosciences (MBX) stake by 30% in Q1 2026, buying an estimated $717K and bringing the position to 90,634 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Manulife (Manufacturers Life Insurance) first reported a position in MBX in Q3 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 90,634 shares of MBX Biosciences worth $2.71M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 21,083 MBX Biosciences shares in Q1 2026, an estimated $717K.
  • MBX Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1379 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in MBX Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.